APA
Sebastian M., Schröder A., Scheel B., Hong H. S., Muth A., von Boehmer L., Zippelius A., Mayer F., Reck M., Atanackovic D., Thomas M., Schneller F., Stöhlmacher J., Bernhard H., Gröschel A., Lander T., Probst J., Strack T., Wiegand V., Gnad-Vogt U., Kallen K., Hoerr I., von der Muelbe F., Fotin-Mleczek M., Knuth A. & Koch S. D. (20190522). A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. : Cancer immunology, immunotherapy : CII.
Chicago
Sebastian Martin, Schröder Andreas, Scheel Birgit, Hong Henoch S, Muth Anke, von Boehmer Lotta, Zippelius Alfred, Mayer Frank, Reck Martin, Atanackovic Djordje, Thomas Michael, Schneller Folker, Stöhlmacher Jan, Bernhard Helga, Gröschel Andreas, Lander Thomas, Probst Jochen, Strack Tanja, Wiegand Volker, Gnad-Vogt Ulrike, Kallen Karl-Josef, Hoerr Ingmar, von der Muelbe Florian, Fotin-Mleczek Mariola, Knuth Alexander and Koch Sven D. 20190522. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. : Cancer immunology, immunotherapy : CII.
Harvard
Sebastian M., Schröder A., Scheel B., Hong H. S., Muth A., von Boehmer L., Zippelius A., Mayer F., Reck M., Atanackovic D., Thomas M., Schneller F., Stöhlmacher J., Bernhard H., Gröschel A., Lander T., Probst J., Strack T., Wiegand V., Gnad-Vogt U., Kallen K., Hoerr I., von der Muelbe F., Fotin-Mleczek M., Knuth A. and Koch S. D. (20190522). A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. : Cancer immunology, immunotherapy : CII.
MLA
Sebastian Martin, Schröder Andreas, Scheel Birgit, Hong Henoch S, Muth Anke, von Boehmer Lotta, Zippelius Alfred, Mayer Frank, Reck Martin, Atanackovic Djordje, Thomas Michael, Schneller Folker, Stöhlmacher Jan, Bernhard Helga, Gröschel Andreas, Lander Thomas, Probst Jochen, Strack Tanja, Wiegand Volker, Gnad-Vogt Ulrike, Kallen Karl-Josef, Hoerr Ingmar, von der Muelbe Florian, Fotin-Mleczek Mariola, Knuth Alexander and Koch Sven D. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. : Cancer immunology, immunotherapy : CII. 20190522.